Grantclosed🌐 United StatesPAR-25-034

Novel Assays to Address Translational Gaps in Treatment Development (UG3/UH3 Clinical Trial Optional)

National Institutes of Health

Details?

Posted: Nov 21, 2024
Response deadline: Jun 20, 2025, 12:00 AM UTC
Type: Grant
Category: 93.242
Status: closed
Buyer: National Institutes of Health
Department: HHS-NIH11
Jurisdiction: United States
Reference #: PAR-25-034

Doc Type: synopsis
Opp Status: archived

Similar past solicitations

IDeA Clinical and Translational Research Development (CTR-D) Award (P20-Clinical Trial Optional)
United States · Aug 29, 2023
Development of Novel or Improved Infertility Technologies (R61/R33 Clinical Trial Optional)
United States · Sep 22, 2025
Development of Medications to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)
United States · Jan 3, 2025
Digital Health Technology Derived Biomarkers and Outcome Assessments for Remote Monitoring and Endpoint Development (UG3/UH3 - Clinical Trial Optional)
United States · Nov 13, 2024
Device Based Treatments for Substance Use Disorders (UG3/UH3 Clinical Trial Optional)
United States · Jul 12, 2024
Viral INfections in the Young Lung- The VINYL Clinical Consortium (UG3/UH3 Clinical Trial Optional)
United States · Sep 18, 2025

Finding similar opportunities…

This listing is a summary from United States's open procurement data. We ingest every field the feed publishes; the full solicitation documents are on the source portal.